Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

被引：0

作者：

Korb, M. ^{[1
]}

Peck, A. ^{[2
]}

Berger, K. ^{[3
]}

James, M. ^{[4
]}

Ghoshal, N. ^{[5
]}

Healzer, E. ^{[6
]}

Henchcliffe, C. ^{[1
]}

Khan, S. ^{[7
]}

Mammen, P. ^{[7
]}

Patel, S. ^{[8
]}

Pfeffer, G. ^{[9
]}

Ralston, S. ^{[10
]}

Roy, B. ^{[11
]}

Seeley, B. ^{[12
]}

Swenson, A. ^{[13
]}

Mozaffar, T. ^{[1
]}

Weihl, C. ^{[5
]}

Kimonis, V. ^{[1
]}

Alfano, L. ^{[14
]}

机构：

[1] UC Irvine Sch Med, Orange, CA USA

[2] Cure VCP Dis, Americus, GA USA

[3] NYU, Grossman Sch Med, New York, NY USA

[4] John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[5] Washington Univ, St Louis, MO 63110 USA

[6] Thriving Hope Consulting, Vinton, VA USA

[7] UT Southwestern Sch Med, Dallas, TX USA

[8] Wellness Sujata, Wadsworth, OH USA

[9] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada

[10] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[11] Yale Sch Med, New Haven, CT USA

[12] Univ Calif San Francisco, San Francisco, CA 94143 USA

[13] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA

[14] Nationwide Childrens Hosp, Columbus, OH USA

来源：

NEUROMUSCULAR DISORDERS | 2021年 / 31卷

关键词：

D O I：

10.1016/j.nmd.2021.07.372

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP.347

引用

页码：S155 / S156

页数：2

共 50 条

[31] Pancreatic Toxicity of Valosin-Containing Protein (VCP) Inhibitors in Rodents
Wolenski, F. S.
Enos, K.
Gavin, J.
Harrison, S.
Berger, A.
Gould, S.
Mallender, W.
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (01) : 70 - 71
[32] Phenotypic variability in three families with valosin-containing protein mutation
Spina, S.
Van Laar, A. D.
Murrell, J. R.
Hamilton, R. L.
Kofler, J. K.
Epperson, F.
Farlow, M. R.
Lopez, O. L.
Quinlan, J.
DeKosky, S. T.
Ghetti, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) : 251 - +
[33] Valosin-containing protein gene mutations -: Clinical and neuropathologic features
Guyant-Marechal, L.
Laquerriere, A.
Duyckaerts, C.
Dumanchin, C.
Bou, J.
Dugny, F.
Le Ber, I.
Frebourg, T.
Hannequin, D.
Campion, D.
NEUROLOGY, 2006, 67 (04) : 644 - 651
[34] The Valosin-Containing Protein Provides a Novel Mechanism of Preconditioning in vivo
Lizano, Paulo
Rashed, Eman
Depre, Christophe
Qiu, Hongyu
CIRCULATION, 2011, 124 (21)
[35] Antitumor activity of xanthohumol, an inhibitor of valosin-containing protein.
Shikata, Yuki
Kanagaki, Shuhei
Sasazawa, Yukiko
Tashiro, Etsu
Yoshimaru, Tetsuro
Komatsu, Masato
Katagiri, Toyomasa
Imoto, Masaya
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[36] High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma
Cui, Yan
Niu, Ming
Zhang, Xianyu
Zhong, Zhenbin
Wang, Ji
Pang, Da
TUMOR BIOLOGY, 2015, 36 (12) : 9919 - 9927
[37] Valosin-containing protein gene mutations: Clinical and histopathologic features in a series of 16 patients
Stojkovic, T.
Hammouda, E.
Richard, P.
Lopez de Munain, A.
Pnisson-Besnier, I.
Ferrer, X.
Lacour, A. .
Bassez, G.
Lacomblez, I.
Lacene, E.
Eymard, B.
NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 850 - 850
[38] Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis
Abramzon, Yevgeniya
Johnson, Janel O.
Scholz, Sonja W.
Taylor, J. P.
Brunetti, Maura
Calvo, Andrea
Mandrioli, Jessica
Benatar, Michael
Mora, Gabriele
Restagno, Gabriella
Chio, Adriano
Traynor, Bryan J.
NEUROBIOLOGY OF AGING, 2012, 33 (09)
[39] Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma
Yamamoto, S
Tomita, Y
Hoshida, Y
Iizuka, N
Kidogami, S
Miyata, H
Takiguchi, S
Fujiwara, Y
Yasuda, T
Yano, M
Nakamori, S
Sakon, M
Monden, M
Aozasa, K
CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5558 - 5565
[40] Valosin-containing protein and neurofibromin interact to regulate dendritic spine density
Wang, Hsiao-Fang
Shih, Yu-Tzu
Chen, Chiung-Ya
Chao, Hsu-Wen
Lee, Ming-Jen
Hsueh, Yi-Ping
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12): : 4820 - 4837

← 1 2 3 4 5 →